Stock profile

Alkermes plc. (ALKS)

ALKS · Latest close — as of Oct 13, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
Data unavailable
No price in range
Tracked funds holding
3 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
1
vs previous quarter

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Deep Track Capital3.05%4,000,000ADDED (+11.4%)
Baker Bros. Advisors2.63%10,012,267HELD
RTW Investments0.75%1,672,356HELD

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end. Fund counts here aggregate every share class mapped to this ticker; research headlines cite filer counts as they stood at publication, so a count here can differ from a headline by a holder (see Methodology, "How holder counts are counted").

Exited this quarter: Avoro Capital Advisors.

All institutions · Form 13F

Institutions holding422 of 8,857 filers
Long-only filers among them421
Change vs 2026 Q1+44 net · 406 entered · 362 exited
Shares reported, all filers177,453,305
Reported value, all filers$8.9B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Short interest

Shares short · Sep 15, 202615,156,775
Days to cover10.70

Shares short at recent settlements — Jun 30, 2026: 17.5M · Jul 15, 2026: 15.0M · Jul 31, 2026: 14.4M · Aug 14, 2026: 14.8M · Aug 31, 2026: 14.7M · Sep 15, 2026: 15.2M.

Source: FINRA Equity Short Interest (biweekly settlement data).

Insider trading · Form 4

Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 14, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

This stock does not currently pass any tracked screen.

Related stocks

Also held by the tracked funds that hold ALKS: TANGO THERAPEUTICS INC (TNGX) · STRUCTURE THERAPEUTICS INC (GPCR) · CYTOKINETICS INC (CYTK) · AVALO THERAPEUTICS INC (AVTX) · Immunovant, Inc. (IMVT) · XENCOR INC (XNCR) · Verastem, Inc. (VSTM) · COMPASS Pathways plc (CMPS) · IMMUNOCORE HOLDINGS PLC-ADR (IMCR) · Guardant Health, Inc. (GH).

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.